BioMarin to Host First Quarter 2026 Financial Results Conference Call and Webcast on Monday, May 4, 2026, at 4:30pm ET
Rhea-AI Summary
BioMarin (NASDAQ: BMRN) will host a conference call and webcast on Monday, May 4, 2026 at 4:30 p.m. ET to discuss first quarter 2026 financial results and provide a general business update. Alexander Hardy, president and CEO, will host the call.
Dial-in and replay numbers are provided and a live audio webcast and one-week replay will be available via the investor site: https://investors.biomarin.com/.
AI-generated analysis. Not financial advice.
Positive
- None.
Negative
- None.
News Market Reaction – BMRN
On the day this news was published, BMRN gained 1.18%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
BMRN was down 1.48% pre-announcement, while peers showed mixed moves: BBIO appeared in momentum scanners up about 5.08% and RPRX down about 3.70%, indicating stock-specific dynamics rather than a broad biotech move.
Previous Conferences,earnings Reports
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Feb 17 | Earnings call notice | Neutral | +0.1% | Announced Q4 and full-year 2025 results call and webcast timing. |
| Jul 22 | Earnings call notice | Neutral | +4.7% | Scheduled Q2 2025 financial results call with webcast access details. |
| Apr 17 | Earnings call notice | Neutral | +0.6% | Set date and time for Q1 2025 financial results call and update. |
| Feb 05 | Earnings call notice | Neutral | +2.1% | Announced Q4 2024 and full-year 2024 results call and webcast details. |
| Oct 16 | Earnings call notice | Neutral | -0.4% | Announced Q3 2024 financial results call with replay information. |
Scheduling earnings calls and webcasts has historically led to modest, mostly positive price reactions, suggesting these notices are treated as routine but slightly constructive catalysts.
Recent news for BioMarin highlights steady operational progress and recurring communication around financial results. Prior conference call scheduling announcements in 2024 and 2025 produced small mostly positive moves between roughly flat and mid-single digits. Alongside this, the company has reported growing revenues, product data, regulatory approvals, and strategic transactions. Today’s announcement of a Q1 2026 results call fits this established pattern of routine investor communications ahead of detailed earnings releases.
Historical Comparison
In past conferences/earnings call notices, BMRN saw an average move of about 1.41%, suggesting today’s Q1 2026 call announcement fits a historically low-volatility pattern for this tag.
The company has consistently pre-announced quarterly conference calls and webcasts, maintaining a regular cadence of earnings communications from Q3 2024 through full-year 2025 into Q1 2026.
Market Pulse Summary
This announcement sets the schedule for BioMarin’s first quarter 2026 financial results call on May 4, 2026 at 4:30 p.m. ET, continuing its pattern of regular quarterly communications. Historical earnings call notices under the same tag have produced modest average moves of about 1.41%. Investors may focus on how upcoming results align with prior 2025 revenues of $3.22B, 2026 guidance ranges, and integration of recent acquisitions.
AI-generated analysis. Not financial advice.
Dial-in Number
International Dial-in Number: 646-307-1963
Conference Call ID: 3424435
International Replay Dial-in Number: 609-800-9909
Playback ID: 3424435
Interested parties may access a live audio webcast of the conference call via the investor section of the BioMarin website, https://investors.biomarin.com/. A replay of the call will be archived on the site for one week following the call.
About BioMarin
BioMarin is a leading, global rare disease biotechnology company focused on delivering medicines for people living with genetically defined conditions. Founded in 1997, the
Contacts: | ||
Investors | Media | |
Traci McCarty | Marni Kottle | |
BioMarin Pharmaceutical Inc. | BioMarin Pharmaceutical Inc. | |
(415) 455-7558 | (650) 374-2803 |
View original content to download multimedia:https://www.prnewswire.com/news-releases/biomarin-to-host-first-quarter-2026-financial-results-conference-call-and-webcast-on-monday-may-4-2026-at-430pm-et-302753431.html
SOURCE BioMarin Pharmaceutical Inc.